ArticleFrontiers in nutrition2026
Dietary Inflammatory Index and risk of nonalcoholic fatty liver disease: nonlinear associations, metabolic mediation, and external validation.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is a common metabolic disorder characterized by chronic low-grade inflammation. The Dietary Inflammatory Index (DII) reflects the inflammatory potential of habitual diet and has been associated with several cardiometabolic diseases. However, the relationship between DII and NAFLD is not fully clarified. In particular, it remains unclear which metabolic factors mediate this association, and whether findings based largely on NHANES data can be confirmed in independent local populations. Methods: This cross-sectional study included adults from NHANES and an independently collected local cohort. Multivariable logistic regression was used to assess the association between DII and NAFLD. Restricted cubic spline models examined dose-response patterns. Subgroup analyses evaluated the consistency of the findings. Mediation analyses quantified the indirect effects of metabolic factors in the DII-NAFLD association. Results: In the NHANES analysis, higher DII scores were independently associated with an increased risk of NAFLD after adjustment for demographic, socioeconomic, and clinical covariates. Restricted cubic spline analysis indicated a nonlinear association, with NAFLD risk rising more steeply at higher DII levels. Mediation analyses demonstrated that triglycerides, fasting plasma glucose, and insulin partially mediated the DII-NAFLD relationship, although a significant direct effect of DII persisted. Consistent findings were observed in the independent local cohort, where higher dietary inflammatory scores were also associated with greater NAFLD risk. Conclusion: DII was positively associated with NAFLD and showed a nonlinear dose-response pattern. This association was partially explained by glucose and lipid metabolic disturbances, and machine learning analysis identified DII as an important predictor of NAFLD. Consistent findings in the local cohort supported the robustness of this association. However, causal relationships cannot be established due to the cross-sectional design.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.